SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Bill Wexler's Profits of DOOM -- Ignore unavailable to you. Want to Upgrade?


To: Spunky Beaver who wrote (1646)7/17/1998 4:14:00 PM
From: Bill Wexler  Respond to of 4634
 
Apparently they met with the FDA to discuss "requirements for resubmission of NDA". I don't know if that means they are going to conduct yet another round of sloppy clinical trials.

The Woodlands, Texas biotech frauds such as TXB and ZONA can play these games for years on end. I wouldn't reshort TXB just yet. Watch it for a few weeks.

At this point I would avoid reshorting TXB and concentrate on building a short position in ZONA.